Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...

During the 1980s and 1990s, Ghanaian artists created vibrant hand-painted movie posters to promote Hollywood blockbuster films. These posters served as promotional material for mobile cinemas that ...

MANILA, Philippines — Muling hinugot ng Strong Group Athletics (SGA) si two-time PBA Finals Most Valuable Player (MVP) Mikey Williams upang palakasin ang lineup nito sa 34th Dubai International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

MANILA, Philippines — Nasa 150 Filipinos ang naapektuhan ng wildfires sa Los Angeles at kasalukuyang nananatili sa Evacuation Center, ayon sa Department of Foreign Affairs (DFA). “We have ...

We introduce Sana, a text-to-image framework that can efficiently generate images up to 4096 × 4096 resolution. Sana can synthesize high-resolution, high-quality images with strong text-image ...

Ikaw naman, lovelife kaagad,” Vice said. David said that he’s also “single” in terms of business, so Vice asked again, “Single ka ba ngayon?” “Opo,” the Sparkle star said. In the same episode, Vice ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.

Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market's losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%.

Sana’s HIP technology is designed to overcome the immunologic rejection of allogeneic cells. In type 1 diabetes, it also evades the autoimmune rejection of pancreatic beta cells. UP421 cells ...

Today, a brief rundown of news involving Tenvie Therapeutics and Jasper Therapeutics, as well as updates from Sana Biotechnology, Stoke Therapeutics and City Therapeutics that you may have missed.